Cerenome

Nasdaq CNSY · Houston, TX

Works in Neurology · Oncology

Cerenome is a clinical trial sponsor based in Houston, TX, listed as Nasdaq CNSY. It has 4 active clinical trials with 175 planned participants, in Neurology and Oncology. Since 2021 it has completed 1 trial and stopped 0 early.

Trial track record · since 2021

4Active trials175 planned participants
1Completed0 with results posted
0Stopped earlyterminated, withdrawn or suspended

Financials · Nasdaq CNSY

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

Pipeline · 4 active trials

StageTrialStatus

On the market · 0 products

No marketed products under this name.

Questions about Cerenome

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-05.

Products come from FDA's drug application database and, for vaccines, cell and gene therapies and blood products, FDA's Purple Book of licensed biologics; checked 2026-10-24.

Approve Suite is not affiliated with Cerenome.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.